Risk factors for lethal outcome in patients with bullous pemphigoid: Low serum albumin level, high dosage of glucocorticosteroids, and old age

Archives of Dermatology

Volumn 138, Issue 7, 2002, Pages 903-908

  Rzany, Berthold ^a,i   Partscht, Karin ^b   Jung, Martin ^a   Kippes, Werner ^d   Mecking, Dieter ^e   Baima, Bozena ^f   Prudlo, Christin ^g   Pawelczyk, Beata ^h   Messmer, Elisabeth M ^c   Schuhmann, Monika ^a   Sinkgraven, Ronald ^a   Büchner, Lutz ^g   Büdinger, Lioba ^h   Pfeiffer, Christine ^g   Sticherling, Michael ^f,j   Hertl, Michael ^h,k   Kaiser, Hans Wilhelm ^e   Meurer, Michael ^g   Zillikens, Detlef ^d   Messer, Gerald ^b  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY OF BONN   (Germany)

^f UNIVERSITY OF KIEL   (Germany)

^g DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^h RWTH AACHEN UNIVERSITY   (Germany)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j UNIVERSITY OF LEIPZIG   (Germany)

^k UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; PREDNISOLONE; SULFONE DERIVATIVE; TETRACYCLINE;

AGE; ALBUMIN BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ELDERLY CARE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; FUTUROLOGY; GERMANY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; LETHALITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PEMPHIGOID; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; STEROID THERAPY; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEMPHIGOID, BULLOUS; PREDNISOLONE; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SURVIVAL ANALYSIS;

EID: 0036288111     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions
2. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany
3. Survival prognosis in pemphigoid: A cohort analysis of 78 patients
4. Anti-BP 180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: A cohort analysis of 94 elderly patients
5. High risk of death in elderly patients with extensive bullous pemphigoid
6. Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence
7. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls
8. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2
9. Bullous pemphigoid: The latest in diagnosis, prognosis, and therapy
10. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid
11. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies
12. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies
13. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid
14. Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: A comparative multicenter study
15. Nicotinamide and tetracycline therapy of bullous pemphigoid
16. Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid
17. Lack of predictive factors for the clinical course of bullous pemphigoid
18. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid
19. IgG, IgA and IgE antibodies against the ectodomain of BP 180 in patients with bullous and circatricial pemphigoid and linear IgA bullous dermatosis
20. Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons
21. Hepatocellular carcinoma in the United States: Prognostic features, treatment outcome, and survival
22. Are serum albumin and cholesterol reliable outcome markers in elderly dialysis patients?
23. Is plasma albumin concentration useful in the assessment of nutritional status of hospital patients?
24. Prediction of survival for older hospitalized patients: The HELP survival model
25. Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid